from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0188/-

LFCtreatmentdescriptionclass of inhibitor

0.021

Amikacinug/mL Amikacintranslation

0.028

Cap5-10ug/mL Capreomycintranslation

-0.540

Rox10-50 ug/mL Roxithromycintranslation

-0.594

SM2-5 ug/mL Streptomycintranslation

-0.463

Tet5-10 ug/mL Tetracyclinetranslation

-1.123

Rif0.2-5ug/mL Rifampicintranscription

-0.797

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.825

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.880

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.248

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.437

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.649

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.838

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.425

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.117

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.430

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.175

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.509

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.158

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.328

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.280

KCN5-20 ug/mL Potassium cyaniderespiration

0.154

NaN30.2-2 mM Sodium aziderespiration

0.639

Nigericin50 uM Nigericinrespiration

2.395

TRC10-150 ug/mL Triclosanrespiration

1.349

TRZ10-25 ug/mL Thioridazinerespiration

-0.202

Valinomycin0.5-10 uM Valinomycinrespiration

-0.894

ZnSO42 mM ZnSO4respiration

0.680

menadione6-10 ug/mL Menadionerespiration

-0.718

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.707

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.529

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.873

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.211

NRP_1Non-replicating persistence stage 1dosRassociated

-0.473

Amp0.2mg/mL AmpicillincellWall

-0.539

Cephalexin20-100 ug/mL CephalexincellWall

-0.530

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.855

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.665

EMB10-20 ug/mL EthambutolcellWall

-0.442

Eta12-40 ug/mL EthionamidecellWall

-0.423

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.446

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.826

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.965

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

2.055

BZA0.12 mg/mL BenzamidearomaticAmides

1.505

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.211

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.076

H2O24 mM hydrogen peroxideDNAdamaging

-0.199

Levo10 ug/mL LevofloxacinDNAdamaging

-0.570

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.546

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.494

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.619

UVUV-irradiationDNAdamaging

0.085

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.873

Antimycin12.5-50 ug/mL Antimycin A?

-0.883

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.514

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.682

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.128

PA8240.2-2 ug/mL PA-824?

-0.075

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.578

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.776

Verapamil50 uM Verapamil?

-0.578

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.125

methoxatin10-20 ug/mL Methoxatin?